FDA device decision timelines get longer as approvals climb, report finds

The FDA approved more medical devices in the first half of 2026 than the prior-year period, but approval timelines have grown substantially longer, according to a BTIG analysis. The analyst noted that while increased approvals signal activity, extended decision times may increase costs and financial risk for device developers navigating the clearance process.